As a HGF-antagonist and angiogenesis inhibitor, the NK4 gene has also been investigated in GC; human BM-MSCs have been used as a gene delivery vehicle for NK4 gene therapy for the human GC cell line MKN45. This evidence concerns the gene HGF and gastric cancer.